Mandate

Vinge advises SEB in connection with its SEK 15 billion rights issue

February 05, 2009

Skandinaviska Enskilda Banken AB (publ) has resolved to carry out a new share issue with preferential rights for the shareholders. Through the rights issue, which is fully committed and underwritten, the bank will raise approximately SEK 15 billion excluding transaction costs. The rights issue is subject to approval by the bank’s annual general meeting on 6 March 2009.

Vinge’s team is led by Hans Wibom and Mattias Friberg. The team also include, among others, Emil Hedberg, Petter Kjöllerström and Peter Larsson.

Related

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024

Vinge advises Triton in connection with the divestment of Norstat to Nalka Invest

Vinge advises Triton Smaller Mid-Cap Fund I (“Triton”) in connection with the divestment of Norstat, a leading data collector for market research, to Nalka Invest.
April 12, 2024